Effect of aripiprazole on behaviour and leukocyte phagocytosis in the olfactory bulbectomy model of depression in rats
| Authors | |
|---|---|
| Year of publication | 2008 |
| Type | Article in Periodical |
| Magazine / Source | European Neuropsychopharmacology |
| MU Faculty or unit | |
| Citation | |
| Field | Pharmacology and pharmaceutical chemistry |
| Keywords | aripiprazole; olfactory bulbectomy; immunity; behaviour; depression; animal model |
| Description | Aripiprazole is an atypical antipsychotic, which displays partial agonist activity at the dopamine D2 receptor and is approved also for the treatment of affective disorders. Present study was undertaken to evaluate the applicability of the well-established olfactory bulbectomy (OB) rat model of experimental depression for the assessment of aripiprazole antidepressant effects. Since the affective disorders are often accompanied by the immune system dysfunction [2], the leukocyte phagocytosis representing the cell immune function was measured together with the behavioural changes. Aripiprazole exhibited a significant positive influence on the impaired behavioural and immune changes in the OB rats serving as model of depression. Thus, chronic treatment with this antipsychotic drug can modulate the cell immune function, which may add to its clinical efficacy. |
| Related projects: |